Severe bullous drug reaction after COVID-19 mRNA vaccination.

Irmer, Marie Luise; Nast, Alexander; Ghoreschi, Franziska; Vogt, Annika; Ghoreschi, Kamran

Irmer, Marie Luise; Nast, Alexander; Ghoreschi, Franziska; Vogt, Annika; Ghoreschi, Kamran.

Irmer ML; Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Nast A; Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Ghoreschi F; Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Vogt A; Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Ghoreschi K; Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

J Dtsch Dermatol Ges ; 20(11): 1509-1511, 2022 11.

Article in English | MEDLINE | ID: covidwho-2078423

Subject(s)

COVID-19; Drug-Related Side Effects and Adverse Reactions; Pemphigoid, Bullous; Humans; COVID-19/prevention & control; Vaccination; RNA, Messenger

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pemphigoid, Bullous / Drug-Related Side Effects and Adverse Reactions / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Dtsch Dermatol Ges Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Ddg.14867

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google